News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Reckitt Benckiser Plc Faces $145.6 Million Lawsuit Over Gaviscon
April 19, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - Britain's health authorities are suing consumer goods group Reckitt Benckiser (RB.L) for 89 million pounds ($145.6 million)over the supply of its heartburn medicine Gaviscon, the company said on Sunday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Policy
Monarez Fired From Top CDC Spot Following Friction Over New COVID-19 Vaccine Policy
August 28, 2025
·
3 min read
·
Heather McKenzie
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
·
3 min read
·
Dan Samorodnitsky
COVID-19
CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup
August 26, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’: Report
August 26, 2025
·
2 min read
·
Tristan Manalac